Dr. Craig D Urban, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3190 Antilley Road, Abilene, TX 79606 Phone: 325-672-5603 Fax: 325-672-6570 |
Paras Batuk Ramolia, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3190 Antilley Rd, Abilene, TX 79606 Phone: 812-239-5977 Fax: 325-672-6570 |
Kleesy L Thomas, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3190 Antilley Rd, Abilene, TX 79606 Phone: 325-672-5603 Fax: 325-672-6570 |
Dr. William W Voelter, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3190 Antilley Road, Abilene, TX 79606 Phone: 325-672-5603 Fax: 325-672-5603 |
Sina Aboutalebi, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3190 Antilley Rd, Abilene, TX 79606 Phone: 325-672-5603 Fax: 325-672-6570 |
Dr. Melissa Anne Rubenstein, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 17051 Dallas Pkwy Ste 350, Addison, TX 75001 Phone: 214-702-0029 Fax: 214-382-3453 |
Melissa I Costner, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 17051 Dallas Pkwy Ste 350, Addison, TX 75001 Phone: 214-702-0029 Fax: 214-382-3453 |
Sonya Sunder Jagwani, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 17051 Dallas Pkwy Ste 350, Addison, TX 75001 Phone: 314-374-3614 |
Edward J Zabawski Jr., D.O. Dermatology Medicare: Medicare Enrolled Practice Location: 1312 Claiborne Ln, Aledo, TX 76008 Phone: 765-918-0080 Fax: 888-323-0020 |
Karaneh Karimi, MD Dermatology Medicare: Medicare Enrolled Practice Location: 977 Raintree Cir Ste 120, Allen, TX 75013 Phone: 972-666-0636 Fax: 972-662-8279 |
Anna B Vawter, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 788 S Watters Rd Ste 120, Allen, TX 75013 Phone: 972-649-6999 |
Dr. Susan Mayse Howsden, M.D. Dermatology - Dermatopathology Medicare: Not Enrolled in Medicare Practice Location: 825 Apple Hill Dr, Allen, TX 75013 Phone: 992-359-7206 Fax: 972-359-7207 |
Dr. Jason Kyle Jones, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4302 Wolflin Ave, Amarillo, TX 79106 Phone: 806-355-9866 |
Summer Clark, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1611 Wallace Blvd, Amarillo, TX 79106 Phone: 063-544-9008 |
Dr. William Robert East, Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1901 Medi-park, Suite 6, Amarillo, TX 79106 Phone: 806-355-7421 Fax: 806-358-2381 |
Christi Anne Baker, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4302 Wolflin Ave, Amarillo, TX 79106 Phone: 806-355-9866 Fax: 806-355-4004 |
Elaine Remmers Cook, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2609 Wolflin Vlg, Amarillo, TX 79109 Phone: 806-358-1117 |
Dr. Tyler Enos, MD Dermatology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 4302 Wolflin Ave, Amarillo, TX 79106 Phone: 806-355-9866 |
Dr. James Keith Yeary, MD Dermatology Medicare: Medicare Enrolled Practice Location: 6010 W Amarillo Blvd, Amarillo, TX 79106 Phone: 806-355-9703 Fax: 806-468-1513 |
Rebecca A. Mccarthy, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4512 Van Winkle Dr, Amarillo, TX 79119 Phone: 806-358-1497 Fax: 806-358-1375 |
News Archive
At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.
The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing Teva's Biologics License Application (BLA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
The morphing structure of the brain's "cartilage cells" may regulate how memories change while you snooze, according to new research in eNeuro.
› Verified 7 days ago